Beat Biotherapeutics looked like it was in trouble after its co-founder and CEO died suddenly in June 2009. But the University of Washington spinout is definitely back in business, after recruiting a veteran CEO and raising another $2.5 million to advance an experimental treatment for heart failure.
Life Sciences Discovery Fund supports $750K in health-related technologies
SEATTLE, Washington, March 11, 2013 — The Life Sciences Discovery Fund (LSDF) today announced nearly $750,000 in Proof of Concept grants to three Washington organizations to support transition of promising health-related technologies from concept to commercial product. Also announced was up to $1.4 million in matching funds to the University of Washington to foster technology
Life Sciences Discovery Fund makes grants to commercialize health-related technologies
The Life Sciences Discovery Fund (LSDF) today announced over $1 million in five awards to support commercial development of new health and health-care products within both the non-profit and for-profit sectors in Washington. Two of the five new grants were made under the 2012 Commercialization grant competition and focus on promising diagnostic technologies developed in
U Washington C4C releases its Fall 2012 Commercialization Gap Fund awards, $420K in funding
Nine Research Teams Receive $420,000 to Develop Fledgling Technologies The UW Center for Commercialization (C4C) today announced the award of $420,000 in Commercialization Gap Funds (CGF) to nine UW research teams currently working on promising technologies. The CGF program is a partnership between the C4C and theWashington Research Foundation to provide up to $1.25 million per
U Washington spin-out, Kona Medical, lands Series C funding
Kona Medical Inc. has raised $10 million in new Series C equity and debt financing.That brings its Series C total to $40 million, including $30 million raised in May. The Series C round included two large-cap strategic investors who joined with prior investors Essex Woodlands, Domain Associates, Morgenthaler Ventures, Western Technology Investments, BioStar Ventures, and individuals
Washington PreCede Grants Go To Three, Promising University of Washington’ Health Companies
The Life Sciences Discovery Fund, a Washington state agency established in May 2005, makes (Proof of Concept PreCede) grant investments in innovative life sciences research to benefit Washington and its citizens. Three, EcoGuide Medical, Viket Medical, and Nexgenia are all University of Washington start-up companies
$20 Million W Fund, Focusing on Research Spinouts, Open for Business
We’ve been hearing about a new investment fund for university spinouts in Washington state for close to two years. Starting today, the W Fund is officially ready to start cutting checks—and it’s already started investigating promising research projects from colleges and government R&D labs around the state.
Free Weekly Update
Fund Managers Forum
Twitter
